{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:23:29Z","timestamp":1791296609856,"version":"4.1.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Perioperative injuries to an allograft exacerbate graft rejection, which in humans is primarily mediated by effector memory T cells. IL-6 transcripts in human coronary artery segments rapidly increase posttransplantation into immunodeficient mouse hosts compared with those of pretransplant specimens and fall dramatically by 30 d. Adoptive transfer of human PBMCs allogeneic to the artery 2 d postoperatively results in T cell infiltrates and intimal expansion 4 wk later. Ab neutralization of human IL-6 reduces the magnitude of intimal expansion and total T cell infiltration but increases the relative expression of CD161 while decreasing other Th17 markers. Coculture of MHC class II-expressing human endothelial cells (ECs) with allogeneic CD4+ memory T cells results in T cell activation and EC secretion of IL-6. Neutralizing IL-6 in primary allogeneic T cell\u2013EC cocultures results in enhanced T cell proliferation of CD161+ CD4+ T cells, reduces total T cell proliferation upon restimulation in secondary cultures (an effect dependent on CD161+ T cells), increases expression of FOXP3 in CD161+ T cells, and generates T cells that suppress proliferation of freshly isolated T cells. These data suggest that IL-6 released from injured allograft vessels enhances allogeneic T cell infiltration and intimal expansion in a model of human allograft rejection by inhibiting an increase in CD161+ regulatory T cells.<\/jats:p>","DOI":"10.4049\/jimmunol.1003774","type":"journal-article","created":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T20:02:15Z","timestamp":1321387335000},"page":"6268-6280","source":"Crossref","is-referenced-by-count":64,"title":["Neutralizing IL-6 Reduces Human Arterial Allograft Rejection by Allowing Emergence of CD161+ CD4+ Regulatory T Cells"],"prefix":"10.1093","volume":"187","author":[{"given":"Birgit","family":"Fogal","sequence":"first","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak A","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lebastchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tellides","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S","family":"Pober","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"2025032410522881800_r1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(01)00119-4","article-title":"Chronic rejection","volume":"14","author":"Libby","year":"2001","journal-title":"Immunity"},{"key":"2025032410522881800_r2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1681\/ASN.V971301","article-title":"The prognostic significance of specific arterial lesions in acute renal allograft rejection","volume":"9","author":"Nickeleit","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"2025032410522881800_r3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","article-title":"Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009","volume":"28","author":"Taylor","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"2025032410522881800_r4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.163.4.2267","article-title":"Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes","volume":"163","author":"Heeger","year":"1999","journal-title":"J. Immunol."},{"key":"2025032410522881800_r5","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.175.8.4886","article-title":"Memory T cells and their costimulators in human allograft injury","volume":"175","author":"Shiao","year":"2005","journal-title":"J. Immunol."},{"key":"2025032410522881800_r6","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.179.7.4397","article-title":"Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo","volume":"179","author":"Shiao","year":"2007","journal-title":"J. Immunol."},{"key":"2025032410522881800_r7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int."},{"key":"2025032410522881800_r8","first-page":"791","article-title":"Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells","volume":"138","author":"Salomon","year":"1991","journal-title":"Am. J. Pathol."},{"key":"2025032410522881800_r9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0012.1994.tb00263.x","article-title":"Acute rejection episodes\u2014best predictor of long-term primary cadaveric renal transplant survival","volume":"8","author":"Ferguson","year":"1994","journal-title":"Clin. Transplant."},{"key":"2025032410522881800_r10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00007890-199705150-00013","article-title":"Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes","volume":"63","author":"Leggat","year":"1997","journal-title":"Transplantation"},{"key":"2025032410522881800_r11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ki.1996.74","article-title":"Chronic renal allograft rejection: immunologic and nonimmunologic risk factors","volume":"49","author":"Massy","year":"1996","journal-title":"Kidney Int."},{"key":"2025032410522881800_r12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00007890-199403270-00015","article-title":"The impact of an acute rejection episode on long-term renal allograft survival (t1\/2)","volume":"57","author":"Matas","year":"1994","journal-title":"Transplantation"},{"key":"2025032410522881800_r13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.RES.0000258861.72279.29","article-title":"Interferon-gamma axis in graft arteriosclerosis","volume":"100","author":"Tellides","year":"2007","journal-title":"Circ. Res."},{"key":"2025032410522881800_r14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35003221","article-title":"Interferon-gamma elicits arteriosclerosis in the absence of leukocytes","volume":"403","author":"Tellides","year":"2000","journal-title":"Nature"},{"key":"2025032410522881800_r15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1096\/fj.03-0840fje","article-title":"Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries","volume":"18","author":"Wang","year":"2004","journal-title":"FASEB J."},{"key":"2025032410522881800_r16","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"2025032410522881800_r17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"2025032410522881800_r18","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r19","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.4049\/jimmunol.153.6.2417","article-title":"Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes","volume":"153","author":"Lanier","year":"1994","journal-title":"J. Immunol."},{"key":"2025032410522881800_r20","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/eji.200940257","article-title":"CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC","volume":"40","author":"Maggi","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"2025032410522881800_r21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"2025032410522881800_r22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"key":"2025032410522881800_r23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"2025032410522881800_r24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025032410522881800_r25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M","article-title":"Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro","volume":"31","author":"Stephens","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"2025032410522881800_r27","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"key":"2025032410522881800_r28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"key":"2025032410522881800_r29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2005.04.010","article-title":"Thymic regulatory T cells","volume":"4","author":"Maggi","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"2025032410522881800_r30","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T helper lymphocytes","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"2025032410522881800_r31","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.4049\/jimmunol.172.10.6003","article-title":"Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants","volume":"172","author":"Cobbold","year":"2004","journal-title":"J. Immunol."},{"key":"2025032410522881800_r32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"2025032410522881800_r33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20050855","article-title":"Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen","volume":"202","author":"Knoechel","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025032410522881800_r35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/eji.200838168","article-title":"Is FOXP3 a bona fide marker for human regulatory T cells?","volume":"38","author":"Roncarolo","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"2025032410522881800_r36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.8094901","article-title":"\u201cInfectious\u201d transplantation tolerance","volume":"259","author":"Qin","year":"1993","journal-title":"Science"},{"key":"2025032410522881800_r37","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.4049\/jimmunol.167.9.4814","article-title":"T cell subsets and in vitro immune regulation in \u201cinfectious\u201d transplantation tolerance","volume":"167","author":"Zhai","year":"2001","journal-title":"J. Immunol."},{"key":"2025032410522881800_r38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2353\/ajpath.2010.090292","article-title":"CD4+ regulatory T cells generated in vitro with IFN-gamma and allogeneic APC inhibit transplant arteriosclerosis","volume":"177","author":"Warnecke","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2025032410522881800_r39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"2025032410522881800_r40","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20082286","article-title":"Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation","volume":"206","author":"Das","year":"2009","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"2025032410522881800_r42","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J. Immunol."},{"key":"2025032410522881800_r43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ni872","article-title":"Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes","volume":"4","author":"Messi","year":"2003","journal-title":"Nat. Immunol."},{"key":"2025032410522881800_r44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0041-1345(96)00015-2","article-title":"The \u201cinjury response\u201d: a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes","volume":"29","author":"Halloran","year":"1997","journal-title":"Transplant. Proc."},{"key":"2025032410522881800_r45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.TP.0000080981.90718.EB","article-title":"Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant \u201catheroma\u201d","volume":"76","author":"Valantine","year":"2003","journal-title":"Transplantation"},{"key":"2025032410522881800_r46","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.4049\/jimmunol.179.10.6536","article-title":"IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response","volume":"179","author":"Rao","year":"2007","journal-title":"J. Immunol."},{"key":"2025032410522881800_r47","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1084\/jem.20081661","article-title":"Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection","volume":"205","author":"Rao","year":"2008","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine\u201440 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025032410522881800_r49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0041-1345(96)00718-X","article-title":"Serum interleukin-6 level after cardiac xenotransplantation in primates","volume":"29","author":"Matsumiya","year":"1997","journal-title":"Transplant. Proc."},{"key":"2025032410522881800_r50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0041-1345(00)02393-9","article-title":"Interleukin-6 in chronic renal allograft rejection: influence of nonimmunologic risk factors","volume":"33","author":"Boraty\u0144ska","year":"2001","journal-title":"Transplant. Proc."},{"key":"2025032410522881800_r51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-3274(02)00004-7","article-title":"The role of IL6 cytokines in acute cardiac allograft rejection","volume":"9","author":"Deng","year":"2002","journal-title":"Transpl. Immunol."},{"key":"2025032410522881800_r52","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0735-1097(02)01791-6","article-title":"The interleukin-6\/interleukin-6-receptor system is activated in donor hearts","volume":"39","author":"Plenz","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"2025032410522881800_r53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.tp.0000281384.24333.0b","article-title":"Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation","volume":"84","author":"Liang","year":"2007","journal-title":"Transplantation"},{"key":"2025032410522881800_r54","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.transproceed.2006.08.113","article-title":"Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation","volume":"38","author":"Perez-Villa","year":"2006","journal-title":"Transplant. Proc."},{"key":"2025032410522881800_r55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0008-8749(89)90095-6","article-title":"Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1","volume":"122","author":"Loppnow","year":"1989","journal-title":"Cell. Immunol."},{"key":"2025032410522881800_r56","first-page":"293","article-title":"Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells","volume":"8","author":"Loppnow","year":"1989","journal-title":"Lymphokine Res."},{"key":"2025032410522881800_r57","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.4049\/jimmunol.178.5.3237","article-title":"TCR signaling antagonizes rapid IP-10-mediated transendothelial migration of effector memory CD4+ T cells","volume":"178","author":"Manes","year":"2007","journal-title":"J. Immunol."},{"key":"2025032410522881800_r58","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.182.3.1548","article-title":"Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes","volume":"182","author":"Walker","year":"2009","journal-title":"J. Immunol."},{"key":"2025032410522881800_r59","volume-title":"Principles and Procedures of Statistics: A Biometrical Approach.","author":"Steel","year":"1980"},{"key":"2025032410522881800_r60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00281-003-0135-1","article-title":"Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte\/severe combined immunodeficient mouse","volume":"25","author":"Pober","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"key":"2025032410522881800_r61","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J. Exp. Med."},{"key":"2025032410522881800_r62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4049\/jimmunol.154.1.151","article-title":"Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro","volume":"154","author":"Murray","year":"1995","journal-title":"J. Immunol."},{"key":"2025032410522881800_r63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0008-8749(89)90036-1","article-title":"Cytokine regulation of interleukin 6 production by human endothelial cells","volume":"121","author":"Shalaby","year":"1989","journal-title":"Cell. Immunol."},{"key":"2025032410522881800_r64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","article-title":"The biology of interleukin-6","volume":"74","author":"Kishimoto","year":"1989","journal-title":"Blood"},{"key":"2025032410522881800_r65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin. Immunol."},{"key":"2025032410522881800_r66","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"2025032410522881800_r67","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.4049\/jimmunol.174.8.4761","article-title":"IL-6 increases primed cell expansion and survival","volume":"174","author":"Rochman","year":"2005","journal-title":"J. Immunol."},{"key":"2025032410522881800_r68","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.0501794102","article-title":"IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation","volume":"102","author":"McLoughlin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410522881800_r69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cyto.2007.07.184","article-title":"Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance","volume":"39","author":"Vardam","year":"2007","journal-title":"Cytokine"},{"key":"2025032410522881800_r70","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2004.01.012","article-title":"A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn\u2019s disease","volume":"126","author":"Ito","year":"2004","journal-title":"Gastroenterology"},{"key":"2025032410522881800_r71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00393-003-0547-2","article-title":"[New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction]","volume":"62","author":"Perniok","year":"2003","journal-title":"Z. Rheumatol."},{"key":"2025032410522881800_r72","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14728222.11.5.613","article-title":"The IL-6\/sIL-6R complex as a novel target for therapeutic approaches","volume":"11","author":"Rose-John","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"2025032410522881800_r73","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.164.9.4878","article-title":"IL-6 is required for the development of Th1 cell-mediated murine colitis","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J. Immunol."},{"key":"2025032410522881800_r74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/clin.1997.4420","article-title":"IL-6: insights into novel biological activities","volume":"85","author":"Barton","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2025032410522881800_r75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","article-title":"Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55","volume":"83","author":"Tilg","year":"1994","journal-title":"Blood"},{"key":"2025032410522881800_r76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0167-5699(97)01103-1","article-title":"IL-6 and APPs: anti-inflammatory and immunosuppressive mediators","volume":"18","author":"Tilg","year":"1997","journal-title":"Immunol. Today"},{"key":"2025032410522881800_r77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thromb. Haemost."},{"key":"2025032410522881800_r78","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"2025032410522881800_r79","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/1078-0432.CCR-06-0977","article-title":"Increased frequency of CD4+ cells expressing CD161 in cancer patients","volume":"12","author":"Iliopoulou","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"2025032410522881800_r80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"2025032410522881800_r81","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"2025032410522881800_r82","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410522881800_r83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"2025032410522881800_r84","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"2025032410522881800_r85","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/intimm\/dxn106","article-title":"The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation","volume":"20","author":"Annunziato","year":"2008","journal-title":"Int. Immunol."},{"key":"2025032410522881800_r86","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1073\/pnas.0704397104","article-title":"Allograft rejection mediated by memory T cells is resistant to regulation","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410522881800_r87","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nm.2154","article-title":"In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells","volume":"16","author":"Nadig","year":"2010","journal-title":"Nat. Med."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/12\/6268\/61605419\/1003774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/12\/6268\/61605419\/1003774.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:05:36Z","timestamp":1743145536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/187\/12\/6268\/7977215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1003774","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,12]]}}}